All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Completed, but no date, and reported results | 2004-000786-35 | A phase III, open-label, randomized, comparative study of the antiviral efficacy of ARV therapy with Lopinavir/Ritonavir (LPV/r - Kaletra) in combination with Tenofovir versus SOC (Kaletra in combinat... | bad-data | |
| Completed, but no date, and reported results | 2004-000816-24 | A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen versus Lopinavir/Ritonavir in Combination with Lamivudine/Zidovudine in Antiretr... | bad-data | |
| Reported results | 2004-002163-24 | A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn'... | 2009-02-24 | due-trials |
| Completed, but no date, and reported results | 2004-002934-20 | A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Moderate to Severe Croh... | bad-data | |
| Reported results | 2004-004602-25 | A Phase 3, Multicenter, Randomized, Double-Blind,Double-Dummy, Placebo-Controlled StudyComparing the Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects withModerate to Severe Ch... | 2006-05-17 | due-trials |
| Reported results | 2005-000095-41 | A Multi-Centre Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects who Completed a Preceding Psoriasis Clinical Study with Adalimumab | 2009-10-20 | due-trials |
| Reported results | 2005-001185-14 | Safety and Efficacy of Adalimumab in Patients with Psoriatic Arthritis (PsA)- An Open-Label, Multinational Study to Evaluate the Response to Every-Other Week Adalimumab When Added to Insufficient Stan... | 2006-10-30 | due-trials |
| Reported results | 2005-001430-32 | A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral Naïv... | 2008-07-15 | due-trials |
| Not reported | 2005-001431-30 | A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (TDF... | 2013-07-05 | due-trials |
| Reported results | 2005-004826-21 | Review of Safety and Efficacy With Adalimumab in Patients With Active Ankylosing Spondylitis An Open-Label Study to Evaluate the Response to Adalimumab in Patients Who Have Failed Standard Therapy o... | 2007-05-29 | due-trials |
| Reported results | 2005-004854-29 | One week double-blind, randomized, placebo-controlled, parallel-group, multi-center study with Creon 25.000 Minimicrospheres in subject with pancreatic exocrine insufficiency after pancreatic surgery,... | 2011-07-01 | due-trials |
| Reported results | 2005-005291-32 | A Multi-Center, Randomized, Double-Blind, Placebo − Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab Endoscopy Trial to Evaluate the Effects on Mucosal Healing in Subjects with Cr... | 2008-09-17 | due-trials |
| Reported results | 2006-000577-29 | A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson’s Subjects Receiving Optimized Treatments with Pa... | 2011-09-20 | due-trials |
| Reported results | 2006-000578-53 | Open-Label, 12-Month Safety and Efficacy Study of Levodopa – Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects | 2012-10-25 | due-trials |
| Reported results | 2006-000748-14 | A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhibito... | 2008-11-10 | due-trials |
| Reported results | 2006-001363-31 | Estudio VITAL- Estudio del activador del receptor de la vitamina D selectivo (Paricalcitol) para la reducción de la albúmina: Estudio multicéntrico de fase II, prospectivo aleatorizado, a doble ciego ... | 2009-05-26 | due-trials |
| Reported results | 2006-002078-23 | A Multi-Center, Open-Label Study of the Fully Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Moderate to Severe Crohn s Disease | 2008-09-05 | due-trials |
| Reported results | 2006-002781-20 | A Multicenter, Randomized, Double-blind, Placebo controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Moderately to Severely A... | 2010-08-18 | due-trials |
| Reported results | 2006-002782-40 | A Multicenter, Randomized, Double-blind, Placebo controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Moderate... | 2010-03-03 | due-trials |
| Reported results | 2006-002830-38 | A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT-751 in Combination with Pemetrexed Versus Pemetrexed Alone in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer | 2009-01-05 | due-trials |
| Reported results Terminated | 2006-002838-38 | A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT-751 in Combination with Docetaxel Versus Docetaxel Alone in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer | 2007-12-11 | due-trials |
| Exempt, with results | 2006-003298-28 | A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Small Cell Lung Cancer (SCLC) or other non-hematological malignancies. | 2010-12-29 | not-yet-due |
| Reported results | 2006-004139-31 | A Multicenter, Randomized, Double-Period, Double − Blind Study to Determine the Optimal Protocol for Treatment Initiation with Methotrexate and Adalimumab Combination Therapy in Patients with Early Rh... | 2010-09-03 | due-trials |
| Trial is partly outside EEC, and reported results | 2006-004814-41 | A Multi-center, Double-blind Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects with Moderate to Severe Crohn's Dise... | 2010-07-29 | bad-data |
| Reported results | 2006-005186-18 | Open-Label, 6-12 Months Safety and Efficacy Study of Levodopa Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations | 2012-09-20 | due-trials |
| Reported results | 2007-001139-71 | A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894, Duloxetine and Placebo in Subjects with Diabetic Neuropathic Pain | 2008-11-03 | due-trials |
| Reported results | 2007-001140-47 | A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894 versus Placebo in Subjects with Diabetic Neuropathic Pain | 2008-12-23 | due-trials |
| Reported results | 2007-001689-34 | Paricalcitol capsules benefits in Renal failure Induced cardiac MOrbidity in subjects with Chronic Kidney Disease Stage 3B/4. | 2012-09-14 | due-trials |
| Exempt, with results | 2007-002143-25 | A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia. | 2012-11-23 | not-yet-due |
| Reported results | 2007-003073-97 | A Multi-center, Randomized, Vehicle-Controlled Study to Assess the Efficacy and Safety of Adalimumab in Combination with Topical Treatment (Calcipotriol/Betamethasone) in Subjects with Moderate to Sev... | 2008-12-22 | due-trials |
| Reported results | 2007-004157-28 | A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects with Ulcera... | 2016-12-23 | due-trials |
| Reported results | 2007-004687-47 | A Phase 3, Multicenter, Randomized, Double-Blind Study Comparing the Safety and Efficacy of ABT-874 to Methotrexate in Subjects with Moderate to Severe Chronic Plaque Psoriasis, Incorporating Amendmen... | 2009-12-28 | due-trials |
| Reported results | 2007-005092-33 | Paricalcitol Injection benefits in Renal failure Induced cardiac Morbidity in Subjects with Chronic Kidney Disease Stage 5. Benefici del paracalcitolo iniettabile sulla morbilita` cardiaca indotta ... | 2009-05-22 | due-trials |
| Reported results | 2007-005245-37 | An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | 2012-06-14 | due-trials |
| Reported results | 2007-005905-23 | A Multi-center, Randomized, Double-blind, Placebo − controlled Study Comparing 80 mg of Adalimumab with Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With ... | 2009-06-15 | due-trials |
| Reported results | 2007-005949-38 | A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone as First-line Treatment in Subjects With Locally Recurrent or Metastatic ... | 2009-12-14 | due-trials |
| Reported results | 2007-005955-40 | A Phase 3, Multi-center, Open-label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects who Completed a Preceding Psoriasis Study With ABT-874 | 2011-11-14 | due-trials |
| Trial is partly outside EEC, and reported results | 2007-006494-90 | A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Ped... | 2017-04-04 | bad-data |
| Reported results | 2007-007081-38 | An Open-Label, Randomized Phase 2 Study of ABT-869 in Combination With mFOLFOX6 (Oxaliplatin, 5-Fluorouracil, and Folinic Acid) Versus Bevacizumab in Combination With mFOLFOX6 as Second-line Treatment... | 2012-05-07 | due-trials |
| Reported results | 2007-007107-32 | A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of Carboplatin /Paclitaxel in Combination with ABT-869 Versus Carboplatin/Paclitaxel Alone in Subjects with Advanced or Metastatic Non-Smal... | 2012-04-04 | due-trials |
| Not reported Terminated | 2008-000400-81 | A Multicenter, Randomized, Double Blind, Pramipexole Controlled Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients with Parkinsons Dise... | 2011-05-31 | due-trials |
| Reported results | 2008-000881-22 | A Randomized, Open-label, Study of Lopinavir/ritonavir 400/100 mg Tablet Twice-Daily + Co-formulated Emtricitabine/Tenofovir Disoproxil Fumarate 200/300 mg Once-Daily Versus Lopinavir/ritonavir 400/10... | 2010-10-28 | due-trials |
| Reported results | 2008-004398-16 | A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable RA Patients in Clinical remission | 2012-09-19 | due-trials |
| Reported results | 2008-004587-38 | A Phase 2 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Chronic Hidradenitis Suppurativa | 2011-01-19 | due-trials |
| Reported results | 2008-004919-36 | A Phase 2B, Multi-center, Randomized, Double- blind, Parallel Group, Placebo-controlled, Dose Ranging Study Comparing the Efficacy, Safety, and Pharmacokinetics of Intravenous Infusions of ABT − 874 v... | 2010-06-08 | due-trials |
| Reported results | 2009-010643-14 | A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Axial Spondyloarthritis | 2013-08-08 | due-trials |
| Reported results | 2009-011378-14 | The IMPACT SHPT Study: Study to Evaluate the Improved Management of iPTH with Paricalcitol-centered Therapy vs. Cinacalcet Therapy with Low-dose Vitamin D in Hemodialysis Patients with Secondary Hype... | 2011-06-21 | due-trials |
| Reported results | 2009-011424-64 | A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild-to-Moderate Alzheimer's Disease | 2010-12-13 | due-trials |
| Ongoing | 2009-011625-13 | "PSOGEN:Effect adalimumab op zelfbeeld en seksueel functioneren bij matige en ernstige psoriasis van de anogenitale regio; prospectief, open label pilot onderzoek" | not-yet-due | |
| Reported results Terminated | 2009-012152-24 | A PHASE II, MULTICENTER, RANDOMIZED, CONTROLLED, OPEN-LABEL STUDY OF THE SAFETY, EFFICACY AND PHARMACOKINETICS OF ABT-263 IN COMBINATION WITH DOSE-INTENSIVE RITUXIMAB, OR DOSE-INTENSIVE RITUXIMAB ALON... | 2012-08-15 | due-trials |
| Trial is partly outside EEC, and reported results | 2009-013072-52 | A Multi-centre, Randomised, Double-Dummy, Double-Blind Study Evaluating Two Doses of Adalimumab versus Methotrexate (MTX) in Paediatric Subjects with Chronic Plaque Psoriasis (Ps) | 2015-02-03 | bad-data |
| Trial is partly outside EEC, and reported results | 2009-013091-40 | Compassionate Use Study of Adalimumab in Children 2 to < 4 Years Old or Age 4 and Above Weighing Less Than 15 kg with Active Juvenile Idiopathic Arthritis (JIA) | 2013-03-21 | bad-data |
| Reported results | 2009-013435-38 | An Open-label, Randomized Phase 3 Study of the Efficacy and Tolerability of Linifanib (ABT-869) versus Sorafenib in Subjects with Advanced Hepatocellular Carcinoma (HCC) | 2012-07-30 | due-trials |
| Reported results | 2009-014567-39 | A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Peripheral Spondyloarthritis | 2014-07-09 | due-trials |
| Reported results | 2009-014767-40 | Randomized, Double-Blind, Active-Controlled Trial to Assess the Safety and Immunogenicity of Solvay's Cell-Derived Influenza Vaccine, Including Revaccination, in Elderly subjects. | 2011-06-22 | due-trials |
| Reported results | 2009-015082-31 | A Phase 2 Randomized Clinical Trial of ABT-888 in Combination with Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Subjects with Recurrent High Grade Serous Ovarian Cancer | 2013-06-25 | due-trials |
| Reported results | 2009-016008-22 | A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Inactive Non-infectious Intermediate-, Posterior-, or Pan-uveitis | 2015-05-14 | due-trials |
| Reported results | 2009-016095-68 | A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non infectious In... | 2014-08-29 | due-trials |
| Reported results | 2009-016196-29 | A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Non-infectious Intermediate-, Posterior-, or Pan-uveitis | 2018-05-25 | due-trials |
| Reported results Terminated | 2009-017801-12 | A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ABT-384 in Subjects with Mild-to-Moderate Alzheimer's Disease | 2011-07-06 | due-trials |
| Trial is partly outside EEC, and reported results | 2009-017938-46 | A Double-blind, Placebo-controlled, Multicenter Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects with Enthesitis Related Arthritis | 2015-12-30 | bad-data |
| Reported results | 2010-018350-13 | Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2010/2011. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subj... | 2010-07-01 | due-trials |
| Reported results | 2010-019155-22 | A Prospective, Randomized, Double-Blind, Parallel-Group Study to Compare the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Subjects with Essential Hypertension | 2013-04-30 | due-trials |
| Reported results | 2010-019439-37 | A Phase 3, Prospective, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Intact Parathy... | 2014-12-22 | due-trials |
| Reported results | 2010-019514-24 | A Double-Blind, Randomized, Parallel-Arm, Multi-Center Study to Determine the Dose Response of Methotrexate (MTX) in Combination Therapy with Adalimumab in Subjects with Early Rheumatoid Arthritis. | 2012-11-20 | due-trials |
| Reported results | 2010-020137-10 | An Open-Label, Multicenter, Efficacy and Safety Study to Evaluate Two Treatment Algorithms in Subjects with Moderate to Severe Crohn's Disease | 2017-01-05 | due-trials |
| Reported results | 2010-022455-31 | A Randomized, Open-Label, Multicenter Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics, of ABT-450 with Ritonavir (ABT 450/r) in Combination with ABT-267 and/or ABT 333 With and ... | 2013-09-19 | due-trials |
| Exempt | 2010-023335-41 | A Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed Indolent Lymphoma | 2012-02-28 | not-yet-due |
| Reported results | 2010-024359-99 | A Multicenter, Randomized, Double-Blind, Placebo and Active Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-639 to Placebo in Subjects with Diabetic Neuropathic Pain | 2011-10-26 | due-trials |
| Trial is outside EEC, and reported results | 2011-001661-40 | A Multicenter, Randomized, Double-blind, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Juvenile Rheumatio... | bad-data | |
| Reported results Terminated | 2011-002143-95 | A Multicenter, Randomized, Double-blind, Placebo- and Active-Controlled Study Comparing the Safety and Analgesic Efficacy of ABT-110 to Placebo in Subjects with Chronic Low Back Pain Sperimentazi... | 2013-01-31 | due-trials |
| Not reported Terminated | 2011-002144-27 | A Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Study Comparing the Safety and Analgesic Efficacy of ABT-110 to Placebo in Subjects with Pain from Osteoarthritis of the Knee ... | 2013-01-31 | due-trials |
| Reported results | 2011-002275-41 | A Multicenter, Randomized, Single-Blind Crossover Study of the Safety and Tolerability of Two Adalimumab Formulations in Adult Subjects with Rheumatoid Arthritis. | 2013-01-18 | due-trials |
| Reported results | 2011-002411-29 | An Open-Label Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting. S... | 2015-05-28 | due-trials |
| Reported results | 2011-002913-12 | A Randomized, Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin a... | 2020-09-02 | due-trials |
| Reported results | 2011-003406-24 | A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa | 2014-07-07 | due-trials |
| Reported results | 2011-003427-36 | Randomized, Double-Blind, Multicenter, Phase 2 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced N... | 2014-09-30 | due-trials |
| Reported results | 2011-003478-98 | A Phase 3 Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa. | 2016-08-12 | due-trials |
| Reported results | 2011-003618-18 | A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects ... | 2015-01-22 | due-trials |
| Completed, but no date, and reported results | 2011-003953-25 | A Multicenter, Randomized, Single-Blind Crossover Study of the Safety and Tolerability of Two Adalimumab Formulations in Adult Subjects with Rheumatoid Arthritis. | bad-data | |
| Reported results | 2011-004849-40 | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT 126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibi... | 2013-11-14 | due-trials |
| Reported results | 2011-005127-40 | A Randomized, Double-Blind, Placebo- and Active Controlled Study of the Electrophysiological Effects of ABT-639 on Spontaneous Activity in C Nociceptors in Patients with Diabetic Peripheral Neuropathy... | 2012-11-13 | due-trials |
| Reported results | 2011-005393-32 | An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV) i... | 2017-05-08 | due-trials |
| Reported results | 2011-005740-95 | A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450 with Ritonavir (ABT- 450/r), ABT-267, and ABT-333 With and Without Ribavirin i... | 2014-10-13 | due-trials |
| Reported results | 2011-005762-38 | A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Coadministration of ABT-450 with Ritonavir (ABT-450/r) and ABT-267 in Adults with Chronic Hepatitis C Virus Infection (PEARL-I) | 2015-02-17 | due-trials |
| Reported results | 2011-005924-16 | A 12-week, Double-blind, Randomized Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate /Simvastatin 145/20mg and Fenofibrate / Simvastatin 145/40mg Tablets vs. Matching Mono... | 2014-01-28 | due-trials |
| Reported results | 2012-000535-36 | A multicenter, randomized, double-blind, double dummy, parallel design study to assess pharmacokinetic, pharmacodynamic, safety and immunogenicity of a new adalimumab formulation compared to the curre... | 2013-06-17 | due-trials |
| Reported results Terminated | 2012-000537-39 | Long-Term Safety and Tolerability of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: An Open-Label Extension Study for Subjects Comple... | 2014-02-24 | due-trials |
| Reported results | 2012-000975-18 | Open-label, Randomized, Parallel-Group, Exploratory Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects with Nonalcoholic Steatohepatitis (NASH) and non-t... | 2014-09-29 | due-trials |
| Reported results | 2012-001032-57 | Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Northern Hemisphere Season 2012/2013. An Open-Label, Baseline- Controlled Study in Two Age Groups... | 2012-07-25 | due-trials |
| Reported results | 2012-002019-25 | A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)and ABT-333 Co-administered with Ribavirin (RBV) in Treatment-... | 2014-10-27 | due-trials |
| Reported results | 2012-002035-29 | A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co administered with Ribavirin (RBV) in Treatment-... | 2014-10-23 | due-trials |
| Reported results | 2012-002215-26 | A Double-Blind, Double-Dummy, Randomized, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Intravaginal Micronized Progesterone Caps... | 2016-09-06 | due-trials |
| Reported results | 2012-002993-29 | A Randomized, Open-label, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Crinone 8% intravaginal progesterone gel 90 mg daily for... | 2017-05-26 | due-trials |
| Reported results | 2012-003088-23 | A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered with Ribavirin (RBV) in Adults with Genotype 1 Chronic ... | 2014-09-24 | due-trials |
| Reported results | 2012-003687-52 | A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ... | 2014-08-19 | due-trials |
| Reported results | 2013-000881-12 | Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Northern Hemisphere Season 2013/2014. An Open-Label, Baseline- Controlled Study in Two Age Groups... | 2013-08-03 | due-trials |
| Completed, but no date | 2013-001347-31 | A Double-blind, Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects with Diabetes Mellitus type 2 Est... | bad-data | |
| Reported results | 2013-002819-10 | A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ? 12 years of Age with Pancreatic Exocrine Insufficiency Due to Cysti... | 2014-08-25 | due-trials |
| Reported results | 2014-001042-24 | Randomized, Double-Blind, Active-Controlled Study in Adults to Assess the Safety and Immunogenicity of Abbott’s Candidate Quadrivalent Influenza Vaccine and its Non-Inferiority to Trivalent Influenza ... | 2016-01-06 | due-trials |
| Trial is outside EEC, and reported results | 2014-004491-31 | Multi-center, Open-label, Uncontrolled Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less with Immunocompromised Medical Conditions | bad-data | |
| Reported results | 2014-004519-35 | A Phase II, Multicenter, Parallel-Group, Active-Controlled, Randomized, Double-blind, Dose-Ranging Study to Evaluate the Efficacy and Safety of Different Doses of Creon IR in Subjects with Pancreatic ... | 2015-07-07 | due-trials |
| Trial is outside EEC, and reported results | 2014-004527-42 | A Prospective, Multicenter, Open-label, Non-comparative Study of Safety and Efficacy of Synagis® in Children at High Risk of Severe Respiratory Syncytial Virus Infection in the Russian Federation. | bad-data | |
| Trial is outside EEC, and reported results | 2014-004531-39 | A Multi-Center, Randomized, Double-blind, Placebo-controlled Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease. | bad-data | |
| Trial is outside EEC, and reported results | 2014-004532-18 | A Multi-Center, Open-Label Efficacy, Safety, and Pharmacokinetic Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis | bad-data | |
| Trial is outside EEC, and reported results | 2014-004558-33 | A Multicenter, Open-label Study of the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis | bad-data | |
| Trial is outside EEC, and reported results | 2014-004560-38 | A Multi-Center, Randomized, Double-blind, Placebo-controlled Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease. | bad-data | |
| Reported results | 2015-005482-23 | Randomized, Double-Blind and Active-Controlled Study in Children and Adolescents Aged 3–17 Years to Assess the Safety and Immunogenicity of Abbott’s Candidate Quadrivalent Influenza Vaccine and its No... | 2017-07-14 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2016-004904-74 | A Phase III, Observer-Blind, Randomized, Non-influenza Vaccine Comparator-Controlled, Parallel-Group, Multi-Country Study in Children Aged 6-35 Months to Assess the Safety and Efficacy of Abbott’s Can... | 2020-01-31 | bad-data |